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ABSTRACT 
Objective: The purpose of our work was to conduct technological, analytical, and biological investigations and stability studies of peritoneal dialysis 
(PD) solutions containing glucose and sodium lactate in single-chamber containers. 
Methods: Different formulations of PD solutions were prepared and sterilized at a temperature of 121 °C during 15 m. UV-spectrophotometric 
determination was performed using purified water as a blank. The spectra of the solutions were run in the range of 220 to 400 nm for the 
identification of an absorption maximum (λmax) and measuring the absorbance at 228-230 nm and λmax before and after heat sterilization. λmax of the 
most PD solutions after sterilization was found in the range of 273 to 281 nm. The potentiometric determination was done for pH measuring PD 
solutions before and after sterilization. Alternative analytical procedure of direct argent metric method was employed for fast measuring content of 
chloride ions. Viability of Vero cells was evaluated using 3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) test, neutral red (NR) 
uptake assay, and sulforhodamine B (SRB) test. 
Results: The results showed that the absorbance of the most laboratory batches of PD solutions augments significantly with increasing an autoclave 
heating time to the sterilization temperature and time of its cooling after sterilization. The longer these parameters, the higher is the absorbance at 
228-230 and 273-281 nm indicating 3,4-dideoxyglucoson-3-en (3,4-DGE) and 5-hydroxymethylfurfural (5-HMF) contents, respectively. Glucose 
degradation is practically absent at short terms of heating and cooling an autoclave while sterilized samples are preserved sterile. Stability studies 
showed a significant decrease in the absorbance at 228-230 nm during storage with the achievement of a nadir and the following weak increase; an 
elevation or decrease in the absorption maximum; a substantial decline in the pH of the solution after sterilization and an insignificant pH decrease 
during storage. The viability of kidney cells was the highest in the SRB test and the lowest one was in the MTT test.  
Conclusion: The influence of sterilization regimes on the quality of conventional PD solutions and their stability during storage were studied. The 
highest cytotoxicity was detected in the MTT test, and the lowest one was done in the SRB test, indicating the largest vulnerability of mitochondria 
under the influence of PD solutions compared to the membranes permeability, functioning of kidney cell lysosomes and the ability of cells to 
synthesize proteins. Our studies could be useful in the context of planning development of PD solutions with the purpose of authorization and 
domestic manufacture of these solutions in low-and-middle-income countries. 
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Chronic kidney disease (CKD) is a worldwide public health problem 
caused by diabetes, hypertension, obesity, smoking, aging and other 
diseases. CKD is associated with increased incidences of mortality, 
morbidity and reduced quality of life because of numerous 
complications of CKD (cardiovascular diseases, anemia, etc.). 
According to the World Health Organization data, diseases of kidneys 
and urinary tract contribute to approximately 850 000 deaths every 
year. CKD occupies the 12th leading cause of death and 17th leading 
cause of disability in the world. The prevalence of CKD in the United 
States of America ranges from 1.5% to 15.6%. In India, majority of the 
CKD patients belong to the younger population compared to other 
countries. Progression of CKD leads to end-stage renal disease (ESRD). 
Patients with ESRD require renal replacement therapy (RRT) 
(haemodialysis, peritoneal dialysis (PD) and kidney transplantation) 
[1-3]. Treatment of ESRD is cost prohibitive for most countries. The 
incidence of ESRD in India is 226 per million population and it is 
expected that nearly 220 000 new patients will be added to general 
amounts of patients with ESRD every year [3]. PD is an essential life-
sustained treatment modality of RRT. Approximately 10% of dialysis 
population is treated with PD. The same fig. is observed in India. The 
prevalence of PD patients increases in both developed and developing 
countries [1-3]. PD is widely documented to cost less to health care 
systems in the world. Because of fewer infrastructure requirements, 
PD is more likely to promote equity in dialysis delivery. Most 
countries, which deliver dialysis through a public delivery mechanism, 
employ PD as a first choice [3].  
PD procedure uses sterile solutions in a total daily amount of up to 
8-40 litres depending on PD modality. Solutions containing dextrose 
and sodium lactate are most frequently used, pH of which is 
approximately 5.0-5.5 [4-7, 10]. Steam sterilization is a method of 
choice in order to ensure the sterility of such solutions as other 
methods such as ionizing radiation, pulsed ultraviolet light, 
filtration, and ohmic heat have prohibitive limitations or have not 
been adequately studied for use in the PD solutions manufacture [9]. 
However, during steam sterilization and subsequent storage glucose 
degradation products (GDPs) with cytotoxic properties are formed, 
including formaldehyde, acetaldehyde, methylglyoxal (2-14 µM), 
glyoxal, low molecular acids, 3-deoxyglycosone (3-DG) (325-425 
µM), 3-deoxyaldose-2-en, 3,4-dideoxyglucoson-3-ene (3,4-DGE) (25-
125 µM), 5-hydroxymethylfurfural (5-HMF), and other compounds. 
Glucose degradation is a very complex process as there are a lot of 
degradation routes of glucose and GDPs [6, 7, 10-12]. Studies of the 
last 30 y indicate their adverse effects on the peritoneum and the 
whole organism. 3,4-DGE and traditional solutions with high levels 
of GDPs induce the apoptosis of mesothelial and renal cells in vitro 
by oligomerization of Bax at mitochondria and activating caspase, 
neutrophils and peripheral blood mononuclear cells [4, 12]. GDPs 
bind to reactive amino acid side chains of proteins that leads to the 
formation of advanced glycation end products [8, 11]. Solutions with 
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low glucose and GDPs concentrations are associated with higher 
effluent levels of cancer antigen 125 (CA125), probably reflecting a 
higher mesothelium cells mass [13]. The use of biocompatible 
solutions with neutral pH and low GDPs level leads to less peritoneal 
injury in patients, the better preservation of residual renal function 
[8, 10, 12]. In recent decades, the attention of scientists has been 
focused on the development of more biocompatible solutions and/or 
the use of more advanced sterilization techniques that contribute to 
less glucose degradation [7-9, 13]. In this case, the elaboration of the 
composition of PD solutions is often carried out in a combination 
with a biological research, namely the study of cells viability in the 
presence of PD solutions [6, 7, 10, 11]. While discussions are 
conducted about benefits and disadvantages of novel PD solutions of 
the second generation in the whole world, it is rational to produce 
traditional (conventional) PD solutions with low GDPs content in 
cost-conscious countries to reduce direct out-of-pocket expenditures 
and continue long-term treatment of patients suffering from ESRD 
[7, 8, 13, 14]. Nevertheless, to the best of our knowledge, scientific 
papers do not provide information for production methods and 
long-term stability of any PD solutions, the interrelation of cells 
viability determined with different procedures and studies of the 
viability of monkey kidney cells under influence of PD solutions. 
MATERIALS AND METHODS 
Materials 
The objects of the research were solutions for PD with a content of 
lactate ions of 35 and 40 mmol/l and 1.5%, 2.5 and 4.25% of glucose 
monohydrate in glass and polyvinylchloride (PVC) containers. The 
composition of the tested solutions is shown in table 1. 
 
Table 1: Composition of the tested solutions 
Sample number Ions concentration, mmol/l Glucose monohydrate concentration, g/l Packaging 
Na+ Ca2+ Mg2+ Cl- CH3CH(OH)COO- 
0 154 - - 154 - - glass 
1(10413) 132 1.25 0.25 95 40 15.0 -//- 
2(20413) 132 1.25 0.25 95 40 42.5 -//- 
3(30513) 132 1.25 0.25 95 40 15.0 -//- 
4(40513) 132 1.25 0.25 95 40 42.5 -//- 
5(10415) 132 1.25 0.25 100 35 15.0 -//- 
6(20415) 132 1.25 0.25 100 35 25.0 -//- 
7(30415) 132 1.25 0.25 100 35 42.5 -//- 
8(21116) 132 1.25 0.25 95 40 42.5 PVC 
9(10117) 132 1.25 0.25 95 40 25.0 -//- 
Sterilization of the PD solutions was carried out at 121 °C for 15 min in accordance with the regimes presented in table 2. 
 
Table 2: Sterilization regimes of the tested PD solutions 
Sample Heating time of 
the autoclave to 
121 °C, min 
Sterilization 
time at 121 °C, 
min 
Total time of pressure drop to 
0 atm and staying containers 
in the autoclave until its 
opening, min  
Time of staying 
containers in an 





7 15 14 - simultaneous sterilization 














samples 5 and 7 were 
sterilized in the same 
autoclave as the different 
loadings 
6(20415) 5 15 11 3 
7(30415) 13 15 18 9 - 
 
Methods  
Determination of chloride ions 
Measuring real concentration of chloride ions was carrying out 
according to the following alternative validated procedure. 10 ml of 
a PD solution (5 ml of an isotonic solution of sodium chloride) are 
titrated with 0.1 M solution of silver nitrate using 0.8 ml of potassium 
chromate solution as indicator (0.4 ml of potassium chromate 
solution for an isotonic solution of sodium chloride) to an orange-
yellow colour, stirring constantly. The content of chloride ions 
should be from 95 to 105% of the stated amount [20].  
Each 1 ml of 0.1M silver nitrate is equivalent to 3.545 mg of Cl-. The 
content of chloride ions (X1), in mmol/l, in a PD solution, is 
calculated according to the following formula:  
X1= V1•K•3.545•1000:10:35.45= V1•K•10. 
The content of chloride ions (X2), in mmol/l, in an isotonic solution 
of sodium chloride, is calculated according to the following 
formula:  
X2= V2•K•3.545•1000:5:35.45= V2•K•20, 
where: V1 and V2-volumes of 0,1 M solution of silver nitrate spent on 
titration of a tested PD solution and isotonic solution of sodium 
chloride, ml, respectively; K–a correction coefficient to the molarity 
of 0.1 M solution of silver nitrate. 
Determination of glucose degradation 
The process of glucose degradation was estimated by changing the 
values of pH and the absorbance at 228-230 nm and the wavelength 
of maximum absorption at about 279 nm before and after 
sterilization and during storage. Spectrophotometric analysis was 
carried out using UV-Visible spectrophotometers with 10 mm path 
length quartz cells. 
Measuring solutions pH 
The pH of the tested PD solutions was measured at a temperature 
range of 20 ˚С to 25 ˚С. The limits of the monograph of the British 
Pharmacopeia for PD solutions are 5.0-6.5.  
Analytical equipment used in analytical studies 
Analytical equipment was the following: рН-meters: "рН-150 М" 
(Gomel Plant of Measuring Instruments, Belarus) (1), рН-410 
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(Aquilon, Russian Federation) (2), "Sartorius AG" (Germany), pHS-
3E (China) (3), Seven Compact pH/ion (Germany) (4); spectro-
photometers: "Specord 210 Plus" (5), "Optizen POP" (Mecasys Co. 
Ltd., Korea) (6), "Photometry Hitachi U-2810" (Hitachi High-
Technologies Corporation, Japan) (7), and "Carry 100" (Agilent 
Technologies, Australia) (8).  
Estimation of cytotoxic action of PD solutions  
Cells of the kidney of an African green monkey (Vero cells), obtained 
from the Institute of Microbiology and Virology of National Academy 
of Sciences of Ukraine (Kyiv), were the object of the study in vitro. 
Special equipment used for cell cultivation was the following: 
laminar box, binocular microscope, thermostat with a humidified 
atmosphere (5% CO2 and 95% air), a plate rotary centrifuge, 96-well 
absorbance reader (Tecan's Sunrise absorbance microplate reader), 
single-dose and multichannel variable-volume dispensers from 1 to 
1000 μl, a Goryaev’s camera, electronics laboratory scale, a pH-
meter. Cells were incubated in Roswell Park Memorial Institute 
(RPMI) medium 1640 in a humidified atmosphere of 5% CO2 and 
95% air at 37 °C. This medium contained 4 mmol of L-glutamine, 
10% of fetal bovine serum and 40 μg/ml of gentamicin. The medium 
was changed every 2 d. During the experiment, 100 μl of a 
suspension of cells at a density of 1x105 cells per ml was placed into 
each well of a 96-well plate. The cells were incubated for cells 
adhesion and monolayer formation in the wells during 24 h. Then, 
100 μl of each PD solution and 0.9% solution of sodium chloride 
were added in the wells in two replicates. 100 μl of the culture 
medium was added to the control wells. The plates were incubated 
in the incubator with 5% CO2 at 37 °C for 24 h.  
MTT test  
The MTT test is based on the ability of the mitochondrial membrane 
enzyme, succinate dehydrogenase, and NAD(P)H-dependent cellular 
oxidoreductase enzyme to reduce the yellow salt of 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to 
purple insoluble crystals formed in the cytoplasm of living cells [11, 
15-17]. 0.5% solution of MTT (Sigma) (Hanks's solution as a solvent) 
was filtered through a sterile cellulose acetate membrane filter. After 
the incubation, 10 μl of MTT solution was injected into each well. 
Then incubation was conducted during 3 h in a CO2-incubator. After 
this incubation, the plates were centrifuged at a rate of 1500 rpm for 
5 min, and then a supernatant fluid was removed from the wells and 
50 μl of dimethyl sulfoxide (Sigma) was added to each well to 
dissolve the formazan crystals. The plates were kept at room 
temperature for 30 min, and then the absorbance of the contents of 
all the wells was determined at a wavelength of 540 nm using 
Tecan's Sunrise absorbance microplate reader (Austria). 
SRB test  
The test with sulforhodamine B is based on the ability of this anionic 
dye to interact with cell proteins that allows determining the cells 
ability to synthesize proteins and the degree of cells proliferation. 
After the incubation, the culture medium was carefully removed 
from each well and the wells were washed with a warm phosphate 
buffer solution to remove proteins from the culture medium that 
could significantly affect the results of an experiment with 
sulforhodamine B. Then, 10% solution of trichloroacetic acid in a 
saline solution was added for fixation of the cells and maintained in 
a refrigerator at a temperature of 4 °C for 1 h. Upon completion of 
the fixation, the plates were carefully washed with running water 
and dried on a filter paper. 0.4% solution of sulforhodamine B was 
added to the wells. The plates were kept at room temperature for 60 
min. The wells were washed with 1% aqueous acetic acid solution 
three times with the purpose of removing the dye.  
Then, 100 μl of 10 mmol of the Trise-base solution was added to 
each well to dissolve the dye. The wells are held on a shaker at a 
speed of approximately 250 rotations per min. The absorbance of 
the contents of the wells was determined at a wavelength of 540 nm 
using the Tecan's Sunrise absorbance microplate reader (Austria). 
NR test  
NR test is based on the ability of living cells to absorb and 
accumulate neutral red dye in lysosomes [18]. After the incubation, 
the medium was carefully removed from each well. Cells were 
washed with 150 μl of warm buffer solution. Then, 100 μl of NR 
solution was added to each well. Incubation was carried out in a 
thermostat for 3 h. After the incubation, the NR solution was 
removed and the wells were washed by adding 150 μl of phosphate 
buffer. After removing the buffer, 150 μl of extraction solution was 
added to the well and the plate was gently shaken on the plate 
shaker for 10 min. The absorbance of the wells contents was 
determined at a wavelength of 540 nm using the Tecan's 
Sunrise absorbance microplate reader (Austria). 
In all the cases the cells viability was calculated to the following formula:  
%viability = Viabilitytested/Viabilitymedium x 100%, where 
%viability-the number of viable cells in %, 
Viabilitymedium–the absorbance in the wells with the medium, 
Viabilitytested-the absorbance in the wells with the tested samples. 
Characteristic of date correlation 
For characterization of a correlation coefficient (r) between the two 
magnitudes, Achim Bühl and Peter Zöfel’s classification was used: to 
0.2–a very weak correlation, to 0.5 is a weak one, to 0.7 is a medium 
one, to 0.9 is a high one, and over 0.9 is very high correlation [19]. 
RESULTS AND DISCUSSION 
Our technological research indicates a significant effect of the 
sterilization regime on the content of GDPs in the PD solutions. The 
results of the technological and analytical studies of samples of PD 
solutions are presented in table 3. 
 







∆ рН Absorbance (mean for 2-3 containers) 
before sterilization after sterilization 
at 228-230 nm at 273-286 nm at 228-230 nm at λmax 
sample 1(10413) 
6.491 6.381 0.11 - - 0.326-0.2428 0.033-0.027 at 273-286 
nm, max n/d 




0.301-0.2188 0.024-0.021 at 273-286 
nm, max n/d 




0.302-0.2198 0.017-0.015 at 273-286 
nm, max n/d 
in 50 mo 
5.771 
5.632 
-0.04 - - 0.340-0.2486 0.043-0.034 at 273-286 
nm, max n/d 
5.421 5.441 -0.02 0.327 at 
228 nm 
- 0.301-0.2178 0.016-0.015 at 273-286 
nm, max n/d 




0.319-0.2338 0.018-0.015 at 273-286 
nm, max n/d 
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sample 3(30513) 
6.641 5.631 1.01 0.308-0.221 0.056-0.061 1.310-1.1938 0.744, λmax=273.0 
6.211 5.571 0.64 0.279-0.195 0.026-0.022 1.399-1.2838 0.781, λmax=275.0 
5.721 
 
5.501 0.22 - - 1.161-1.0538 0.573, λmax=276.0 
in 46 mo 
5.224 0.28 - - 0.771-0.6747 0.576, λmax=276.3 
in 50 mo 
5.441 
5.282 
-0.22 - - 0.877-0.7656 0.686, λmax=276.0 
5.401 5.351 0.05 0.296-0.210 0.022-0.018 1.019-0.9168 0.454, λmax=280.0 
5.201 5.17 0.03 0.290-0.205 0.011-0.008 1.032-0.9288 0.581, λmax=281.0 
sample 2(20413) 




1.509-1.3908 0.854, λmax=275.0 
in 44 mo 
5.35 0.13 - - 1.264-1.1477 1.156, λmax=275.5 




1.375-1.2618 0.706, λmax=274.0 
in 44 mo 
5.341 0.16 - - 1.138-1.0297 0.961, λmax=275.3 
5.731 
 




 1.283-1.1728 0.621, λmax=275.0 
 in 44 mo 
5.35 0.08 - - 0.965-0.8647 0.802, λmax=276.6 
in 50 mo 
5.371 
5.202 
-0.02 - - 1.081-0.9616 0.923, λmax=277.0 




1.147-1.0428 0.541, λmax=278 
in 44 mo 
5.261 0.04 - - 0.931-0.8337 0.934, λmax=279.3 
5.241 
 




0.354-0.2688 0.041-0.037 at 273-286 
nm, max n/d 
in 44 mo 
5.261 -0.02 - - 0.317-0.2377 0.043 at 284.4 nm, max 
n/d 
sample 4(40513) 
6.641 5.311 1.33 0.267-0.186 0.017-0.014 3.107-2.9478 2.335, λmax=278  
6.201 5.361 0.84 0.270-0.189 0.021-0.016 2.628-2.4848 1.662, λmax=277 
5.681 5.311 0.37 0.283-0.200 0.020-0.015 2.465-2.3278 1.621, λmax=278  
in 45 mo 
5.014 0.30 - - 1.568-1.4487 1.690, λmax=278 
in 50 mo 
5.251 
5.072 
-0.24 - - 1.587-1.4516 1.695, λmax=279 
5.431 5.251 0.18 0.295-0.211 0.024-0.020 2.194-2.0668 1.357, λmax=280  
5.201 5.151 0.05 0.317-0.229 0.042-0.043 1.995-1.8728 1.282, λmax=281  
sample 7(30415) 
6.481 6.151 0.33 - - 0.2916-0.20285 0.0321-0.0289 at 273-
286 nm, 
max n/d 
6.031 6.131 -0.10 - - 0.2663-0.17845 0.0130-0.0158 at 273-
286 nm, 
max n/d 
in 22 mo 
5.614 0.52 - - 0.324-0.2547 0.073, λmax=270.5 
5.731 5.671 0.06 - - 0.2860-0.19795 0.0202-0.0231 at 273-
286 nm, 
max n/d 
in 26 mo 
5.641 
5.492 
0.03 - - 0.349-0.2666 0.074-0.063 at 273-286 
nm, max n/d 
5.411 5.471 -0.06 0.256-0.169 -0.0059- 
-0.0029 
0.2739-0.18555 0.0050-0.0093 at 273-
286 nm, 
max n/d 
in 22.5 mo 
5.262 0.21 - - 0.374-0.2916 0.102, λmax=276 
5.201 5.171 0.03 0.264-0.175 0.0046- 
-0.0019 




6.441 6.271 0.17 - - 0.2765-0.18915 0.0214-0.0224 at 273-
286 nm, 
max n/d 
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6.031 6.141 -0.11 - - 0.2739-0.18635 0.0183-0.0211 at 273-
286 nm, 
max n/d 




5.612 0.06 - - 0.279-0.2016 0.018-0.014 at 273.0-
286.0 nm, max n/d 





- - 0.294-0.2116 0.027-0.022 at 273-286 
nm, max n/d 
5.441 5.491 -0.04 - - 0.2929-0.20455 0.0200-0.0223 at 273-
286 nm, 
max n/d 
in 22 mon 
5.194 0.30 - - 0.283-0.2117 0.028 at 284.4 nm; max. 
n/d 




6.441 5.721 0.72 0.253-0.174 0.0076-0.0082 1.428-1.3245 0.565, λmax=278.0 
in 15 mo 
5.35 0.37 - - 0.776-0.6797 0.482, λmax=270.5 
6.051 5.651 0.40 0.259-0.179 0.0076-0.0083 1.422-1.3195 0.527, λmax=276.0 
5.721 5.571 0.15 0.258-0.178 0.0068-0.0069 1.249-1.1525 0.385, λmax=278.0 
in 15 mo 
5.263 0.31 - - 0.624-0.5427 0.378, λmax=275.5 
in 22.5mo 
5.352 -0.09 - - 0.719-0.6256 0.468, λmax=276.5 





- - 0.733-0.6366 0.483, λmax=276.5 
5.421 5.391 0.03 0.263-0.181 0.002-0.003 1.190-1.0955 0.382, λmax=281.0  
in 15 mo 
5.113 0.28 - - 0.564-0.4827 0.340, λmax=278.0 
5.211 5.211 0 0.272-0.189 0.004-0.005 1.139-1.0455 0.418, λmax=283  
sample 8(21116) 
6.472 5.632 0.84 0.290-0.2035 0.017-0.021 1.294-1.1876 0.394, λmax=276.3 
in 9 d 
-  - - 1.143-1.0417 0.379, λmax=273.4 
5.902 5.582 0.32 0.290-0.2015 0.009-0.015 1.251-1.1476 0.348, λmax=275.3 
in 9 d 
-  - - 1.100-1.0007 0.335, λmax=272.7 
5.592 5.462 0.13 0.294-0.2045 0.009-0.016 1.163-1.0616 0.302, λmax=278.3 
in 9 d 
-  - - 1.028-0.9327 0.293, λmax=275.4 





- - 0.668-0.5626 0.262, λmax=272 
 
5.412 5.352 0.06 0.306-0.2155 0.013-0.017 1.142-1.0426 0.302, λmax=279.3 
in 9 d 
-  - - 0.992-0.8987 0.281, λmax=277.2 
5.142 
 
5.122 0.02 0.319-0.2265 0.015-0.020 1.050-0.9496 0.302, λmax=282.0 
in 9 d 
- - - - 0.923-0.8307 0.282, λmax=280.0 
 in 3 mo 
 5.182 -0.06 - - 0.643-0.5446 0.246, λmax=277.0 
sample 9(10117) 
6.512 5.394 1.12 0.290-0.206 0.017-0.015 1.252-1.1427 0.705, λmax=272.4 
6.102 5.404 0.70 0.290-0.203 0.012-0.010 1.148-1.0417 0.601, λmax=272.3 
5.452 5.352 0.10 0.307-0.218 0.012-0.008 0.888-0.7806 0.452, λmax=275.5 





- - 0.851-0.7386 0.457, λmax=273.5 
5.092 4.974 0.12   0.912-0.8177 0.465, λmax=279.6 
*-standard deviation (SD) is±0.01 (n=3 measurements of pH of a sample before sterilization); **-SD is±0.05 for measuring pH after sterilization for 
2-3 containers (n=3 measurements of pH of a sample); max n/d–absorption maximum was not detected; 1-8–these fig. identify the analytical 
equipment indicated in the materials and methods section. 
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Currently, the main way of ensuring the sterility of PD solutions is 
thermal sterilization [9, 10]. GDPs are formed during sterilization 
and following storage of PD solutions [4, 10]. The British 
Pharmacopoeia only regulates the 5-HMF content for PD solutions 
containing glucose and sodium lactate or sodium hydrocarbonate. 
The 5-HMF content should be not more than 10 μg for every 25 mg 
of glucose. The content of other GDPs is not regulated by the British 
Pharmacopoeia [20]. However, literature data indicate the cytotoxic 
effect of 3,4-DGE, high concentrations of glucose and low acidic pH of 
these solutions on the renal tubular epithelial cells, peritoneal 
mesothelium cells, etc. [4, 10, 12]. 3,4-DGE has a maximum 
absorption at 228-230 nm [10, 21]. According to our unpublished 
studies, 5-HMF has a maximum absorption at 228 and 284 nm. The 
quality of solutions for PD may be determined by simple 
measurements of the absorbance at 228 and 284 nm [10]. 3,4-DGE is 
considered to be a highly relevant parameter for the development 
and quality control of PD solutions and it enables to control 
sterilization regimes and storage conditions in the pharmaceutical 
manufacture of any solutions containing glucose [5, 6, 10, 21]. 
The experimental data (tables 2 and 3) show that the heating time 
of an autoclave to the sterilization temperature and the cooling 
time after sterilization significantly affects the absorbance of the 
PD solutions at 228 nm and the absorption maximum that 
coincides with the published data for 5 % glucose solution for 
infusions. It was found that the continuation of the temperature 
action in the process of heating and cooling the autoclave leads to 
an increase of the absorbance at 230 and 284 nm [21]. The 
absorbance of the most solutions after sterilization was very high 
at 228-230 nm that is in line with work of Erixon et al. [5]. Glucose 
degradation in solutions containing glucose and sodium lactate is 
practically absent at short terms of heating and cooling an 
autoclave while sterilized samples are preserved sterile. The 
absence of glucose degradation was confirmed by the lack of 
changes in pH and absorption spectrum of laboratory batches 
1(10413), 5(10415), and 7(30415) after sterilization. However, 
during the storage, processes of GDPs formation were observed in 
batch 7(30415): an insignificant pH change of the solutions and 
the presence of a low absorbance at the wavelength of maximum 
absorption, indicating a slight formation of 5-HMF. These data 
coincide with previously published results concerning a weak 
increase of the absorbance of the solution sterilized by sterile 
filtration at 228 and 284 nm during storage [10]. 
The results of the technological experiments show that the GDPs 
content can be reduced if the heating and cooling times of an 
autoclave for each loading are adjusted. The weight of the containers 
is reduced in 0,046-0,138% after the thermal sterilization of 
laboratory batch number 8(21116), which is explained by the 
evaporation of water through the walls of PVC containers. 
The results of a random stability study indicate a significant 
decrease in the absorbance at 228-230 nm in most samples during 
storage after sterilization which is mainly explained by a decrease 
in the 3,4-DGE content, followed by a gradual slight increase in the 
absorbance. The obtained results are in agreement with published 
data for a 50% glucose solution with pH 3.2 and a solution 
containing glucose 1.5% and lactate 35 mmol/l [5, 6, 10]. Erixon et 
al. reported that 3,4-DGE is converted into 3-DG, 5-HMF, later 
degradation products or other unidentified compounds during 
storage [5, 6]. Among degradation products of 5-HMF may be 
levulinic acid (λmax=265-266 nm), acetylacrylic acid, 5-
hydroxymethyl-2-furan carboxylic acid (λmax=247 nm), and 2,5-
furan dicarboxylic acid (λmax=259 nm) [21, 22]. During storage in 
some samples, an increase in the absorbance at the maximum 
occurs, indicating an increase in the 5-HMF content, while in the 
solutions of laboratory batch 8(21116), the absorbance at the 
absorption maximum reduced, indicating a decrease in the 5-HMF 
content. These data confirm a previous assumption that a decrease 
in the 3,4-DGE content may be accompanied by an increase in the 
concentration of 5-HMF or its decrease due to latter degradation 
[5, 10].  
In all the solutions, with exception of laboratory batches 1(10413) 
and 5(10415), there is a significant decrease in pH after sterilization 
and an insignificant decrease in pH during storage, indicating the 
formation of low molecular weight acids after sterilization and, 
respectively, slight glucose degradation with forming acidic GDPs 
during storage. Taking into consideration the complete uncertainty 
of the analysis for pH measurements in various laboratories±0.15 
pH units [23], it is advisable to conduct stability studies at the 
same pH-meter. In the absence of such an opportunity and the 
necessity to conduct research at different pH-meters, the 
conclusions about glucose degradation should be made taking 
into account the complete uncertainty of the pH analysis. pH of 
the developed PD solutions after sterilization and during storage 
met the requirements of the monograph of the British 
Pharmacopeia for PD solutions (5.0-6.5). 
  
Table 4: Quality parameters of the tested solutions and viability of kidney cells in their presence 
Number of samples 




pH before sterilization, 
mean±SD* (n=3 measurements) 
- 5.71±0.01 5.73±0.01 
 




рН after sterilization, mean±SD 
(n=3 measurements at рН 150М) 




Absorbance at λ=228 nm 0.038 0.340 1.081 0.877 1.587 0.294 0.733 0.349 0.668 0.851 



























Chloride content from stated 
amount, (95-105%) 
98.7 100.79 99.61 101.58 99.47 100.75 100.17 99.65 104.21 105.0 
Viability of Vero cells (%) (mean±SD, n=2 two replicates for each sample) 












*-standard deviation (SD) 
 
The above data on the development of the sterilization process 
indicate that optimal sterilization conditions should be established 
for each containers loading and nominal volume, namely the heating 
time of an autoclave to sterilization temperature, the time of 
sterilization of a product at 121 °C, the cooling time of the autoclave 
and cooling conditions of containers after sterilization. It is 
necessary to provide the lowest values of the absorbance of 
solutions at 228-230 nm and at the absorption maximum while 
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maintaining the quality of the product for the sterility. According to 
the literature data, sterilization time of PD solutions ranges from 15 
to 80 min at 121 °C [5, 9, 10]. 
In vitro cell-based assay is widely employed to fast determine the 
cytotoxic activity of different individual compounds, mixtures of 
compounds, toxins, and medicinal products, including PD solutions, 
etc. [7, 15, 17, 25]. Currently, Vero cell line is used in cytotoxicity 
assay [24, 25]. Data on the cytotoxic activity of the tested solutions 
in the MTT, NR and SRB tests are presented in table 4 and fig. 1. 
The intensity of forming formazan crystals in the cytoplasm can be 
judged by the level of mitochondrial activity (cell respiration), which 
is an indicator of functional activity and cell viability. The amount of 
produced formazan is proportial to the number of living cells [15]. It 
was found that the tested samples had the greatest negative effect 
on the kidney cells mitochondria in the MTT test. In this test, the 
cells viability was in the range of 12% to 16% compared with 25 % 
of viability in the presence of 0.9% solution of sodium chloride. 
Sample 5(10415) showed the largest cytotoxic action: the number of 
viable Vero cells was 11.86%±0.29%.  
Similarly, it was found that the tested samples had a negative effect 
on the permeability of the membranes and functioning of kidney cell 
lysosomes in the NR test. Lysosome integrity with concomitant 
binding NR is a highly sensitive indicator of cell viability as the dye 
cannot be retained when a cell dies [18]. In this test, the vitality of 
cells was within the range of 16% to 35%. Compared with the data 
in the control wells, sample 5(10415) also showed the largest 
cytotoxic action. The number of viable cells was 16.32%±1.32%. 
Samples 8(21116) and 9(10117) were of the smallest cytotoxic 
action: 19.87%±0.66% and 27.25%±1.32%, respectively. These data 
are in line with Erixon et al., who stated approximately 43% of cells 
growth inhibition at a dilution of a conventional PD solution with 
medium in the ratio of 3 to 2 in the NR test (3,4-DGE and glucose 
concentration were 13 µmol/l and 2.5%, respectively) [6]. Similar 
data in the NR test were obtained at dilutions of 2 to 1 and 1 to 1 
(65%-95% of the viability of Vero cells). 
In SRB test it was found that the tested solutions for PD had also a 
negative effect on the synthesis of proteins and kidney cells ability to 
proliferation. In this case, the viability of the cells was within the 
range of 29% to 38% compared with 37% of viability in the 
presence of 0.9% sodium chloride solution. The largest cytotoxic 
action was also shown by sample 5(10415). The number of viable 
cells in the Vero cells was 29.32%. Samples 4(40513) and 6(20415) 
showed the smallest cytotoxic action: 35.08%±0.35% and 
37.58%±0.77%, respectively. 
The results of this study confirm the literature data on the cytotoxicity 
of PD solutions [4, 6, 7, 10, 12, 13]. As it was stated by Li et al., limiting 
remesotelization took place independently on glucose concentration 
and finally led to apoptosis [8]. However, it is not yet known what 
factor or combination of these causes cytotoxicity. A relatively 
insignificant viability of Vero cells in the presence of isotonic sodium 
chloride solution can be explained, in particular, by its low pH (5.11). 
Consequently, the results of the cytotoxicity in vitro study suggest 
that the cytotoxic activity of the tested solutions for PD was the 
highest in the MTT test and the lowest in the SRB test. The 
correlation between viability of the cells in the different tests was 
established. The value of the correlation coefficient between the 
viability growth in the MTT test and the increase in the pH of the 
solutions after sterilization was r=0.31. It characterizes this 
correlation between the values as weak one. The opposite 
correlations were found in the SRB and NR tests.  
The negative correlation coefficient was established as-0.38 between 
the viability reducing and the increase in the pH of the PD solution 
after sterilization in the SRB test. A weak, but significantly stronger, 
negative correlation (r=-0,496) was also found between a reduce in 
the cells viability and an increase in the pH solutions in the NR test 
(at pH-meter 150M, fig. 1). 
  
 
Fig. 1: Estimation of Vero cells viability depending on pH of the PD solutions after sterilization 
 
The low data of cell viability are in line with published results 
concerning 100% of cell growth inhibition at a pH of 5.0 [7]. Data of 
the MTT test could be used as an additional tool of improving of 
formulation and/or technology of PD solutions, for instance, 
elevation of pH before and after sterilization, usage of sophisticated 
sterilization regimes, etc. 
Comparing the cells viability correlation with using MTT and NR 
tests, MTT and SRB tests, respectively, negative correlation 
coefficients were established as-0.473 between increasing viability 
in the MTT test and decreasing viability in the NR test, and-0.27 
between increasing viability in the MTT test and decreasing viability 
in the SRB test, respectively (fig. 2). 
  
 
Fig. 2: Correlation of the MTT test with other viability tests 
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These correlations can indicate the different cytotoxicity 
mechanisms and properties of these three tests–inhibition of 
mitochondrial activity and disturbance of mitochondrial integrity in 
the MTT test, disturbance of membranes integrity and lysosomes 
function in the NR test, pH-dependence of NR test, less pH-
dependence of SRB test, and disturbance of protein synthesis, etc. 
Comparing connection of cell viability in the NR test with MTT and 
SRB tests, negative correlation coefficients were also established:-
0.288 between increasing in the viability in the NR test and 
decreasing in the viability in the SRB test and-0.473 between 
increasing viability in the NR test and decreasing viability in the 
MTT test, respectively, (fig. 3) that also confirms the different 




Fig. 3: Correlation of the NR test with other viability tests 
 
All the laboratory batches met the requirements of the monograph 
for PD solutions of the British Pharmacopeia for the indexes of pH 
(5.0-6.5) and chloride content (95%-105% from the stated amount) 
(tables 3 and 4). 
CONCLUSION 
The results of complex studies of the PD solutions containing glucose 
and sodium lactate in single-chamber containers are presented, 
including selective stability study during storage. The effects of 
heating the autoclave to the sterilization temperature and its cooling 
on the formation of 3,4-DGE and 5-HMF are shown. It is determined 
that the larger the time indicators of the autoclave, the more are the 
3,4-DGE and 5-HMF contents. There is a decrease in the absorbance 
at 228-230 nm during storage with a subsequent gradual increase in 
the absorbance, indicating a significant reducing in the 3,4-DGE 
content and a slight it's increasing during storage. During storage an 
increase in the absorbance at the maximum occurs in part of the 
tested samples, indicating an increase in the content of 5-HMF, while 
in other samples the absorbance at the wavelength of maximum 
absorption is reduced indicating a decrease in the content of 5-HMF. 
There is a decrease in the pH of the solutions in most samples after 
sterilization and during storage. An evaluation of the cytotoxic 
activity of the tested solutions was conducted by determining the 
viability of the Vero cells using three tests in vitro. The largest 
cytotoxic activity of the tested PD solutions and isotonic solution of 
sodium chloride was in the MTT test and the lowest one is observed 
in the SRB test. Weak correlations between the three tests were 
established that may indicate quite different mechanisms of 
cytotoxicity determined by each of these tests. 
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